SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-058750
Filing Date
2018-09-26
Accepted
2018-09-26 16:20:33
Documents
2
Period of Report
2018-09-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-36014_18k.htm 8-K 27536
2 EX-99.1 a18-36014_1ex99d1.htm EX-99.1 10767
  Complete submission text file 0001104659-18-058750.txt   39428
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38410 | Film No.: 181088148
SIC: 2834 Pharmaceutical Preparations